Detalles de la búsqueda
1.
Meta-Analysis of 49 Roche Oncology Trials Comparing Blinded Independent Central Review (BICR) and Local Evaluation to Assess the Value of BICR.
Oncologist
; 2023 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905580
2.
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platform.
J Biopharm Stat
; 33(6): 800-811, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36637189
3.
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
N Engl J Med
; 370(8): 709-22, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24552318
4.
Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced ALK-Positive NSCLC With or Without Baseline Central Nervous System Metastases.
JTO Clin Res Rep
; 4(4): 100483, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37025119
5.
Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC.
JTO Clin Res Rep
; 3(7): 100341, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756755
6.
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study).
Eur J Cancer
; 83: 177-184, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28738258
7.
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.
J Clin Oncol
; 33(19): 2166-75, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26014298
8.
Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.
Lung Cancer
; 86(1): 67-72, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25154982
9.
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).
J Thorac Oncol
; 9(6): 848-55, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24807156
10.
Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancer.
Eur J Cancer
; 90: 153-155, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174181
Resultados
1 -
10
de 10
1
Próxima >
>>